Isolated Nerve Terminals as a Model System for the Study of Botulinum and Tetanus Toxins

Bacterial Toxins: Tools in Cell Biology and Pharmacology

Volumn , Issue , 2008, Pages 193-215

  Blasi, J ^a   Link, E ^b   Jahn, R ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Metalloendoprotease; Microinjection; Neurotransmitter; Spontaneously; Synaptobrevin

Indexed keywords

EID: 0344098210     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527614615.ch15     Document Type: Chapter

References (91)

1. Ahnert-Hilger G, Weller U, Dauzenroth ME, et al. (1989a): The tetanus toxin light chain inhibits exocytosis. FEBS Lett. 242: 245-8.
2. Ahnert-Hilger G, Bader MF, BhakDai S et al. (1989b): Introduction of macromolecules into bovine adrenal medullary chromaffin cells and rat pheochromocytoma cells (PC12) by permeabilization with streptolysin O: inhibitory effect of tetanus toxin on catecholamine secretion. J. Neurochem. 52: 1751-8
3. Ahnert-Hilger G, Dauzenroth ME, Habermann E et al. (1990): Chains and fragments of tetanus toxin, and their contribution to toxicity. J. Physiol. (Paris) 84: 229-36.
4. Ahnert-Hilger G, Bigalke H (1995): Molecular aspects of tetanus and botulinum neurotoxin poisoning. Prog. Neurobiol. 46: 83-96.
5. Angaut-Petit D, Molgo J, Cornella JX et al. (1990): Terminal sprouting in mouse neuromuscular junctions poisoned with botulinum type A toxin: morphological and electrophysiological features. Neuroscience. 37: 799-808.
6. Bakry N, Kamata Y, Simpson LL (1991): Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin. J. Pharmacol. Exp. Ther. 258: 830-6.
7. Binz T, Blasi J, Yamasaki S et al. (1994): Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J. Biol. Chem. 269: 1617-20.
8. Bittner MA , Holz RW (1988): Effects of tetanus toxin on catecholamine release from intact and digitonin-permeabilized chromaffin cells. J. Neurochem. 51: 451-6.
9. Blasi J, Chapman ER, Link E et al. (1993a) Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 365: 160-3.
10. Blasi J, Chapman ER, Yamasaki S et al. (1993): Botulinum neurotoxin Cl blocks neurotransmitter release by means of cleaving HPC-1/syntaxin. EMBO J. 12: 4821-8.
11. Boroff DA, Fleck U (1966): Statistical analysis of a rapid "in vivo" method for the titration of the toxin of Clostridium botulinum. J. Bacteriol. 92: 1580-1.
12. Bradford M.M. (1976): A rapid and sensitive method for the quantification of micrograms quantities of protein utilizing the principe of protein-dye binding. Anal. Biochem. 72: 248-54.
13. Cabot JB, Mennone A, Bogan N et al. (1991) Retrograde, trans-synaptic and transneuronal transport of fragment C of tetanus toxin by synpathetic preganglionic neurons. Neuroscience. 40: 805-23.
14. Dayanithi G, Weller U, Ahnert-Hilger G et al. (1992): The light chain of tetanus toxin inhibits calcium-dependent vasopressin release from permeabilized nerve endings. Neuroscience 46: 489-93.
15. DasGupta BR, editor (1993): Botulinum and tetanus neurotoxins. Plenum Press. New York.
16. Davis LE (1993): Botulinum toxin. From poison to medicine. Western Journal of Medicine. 158: 25-29.
17. Dickson EC, Shevky R (1923): Botulism, studies on the manner in which the toxin of Clostridium botulinum acts upon the body. I. The effect upon the autonomic nervous system. J. Exp. Med. 37: 711-31
18. Dolly JO, Black J, Williams RS et al. (1984): Acceptors for botulinum neurotoxin reside on motor nerve terminals and me4diate its internalization. Nature. 307: 457-60.
19. Dreyer F (1989): Peripheral action of tetanus toxin. In: Botulinum Neurotoxin and Tetanus Toxin, (Simpson LL, ed) pp 179-202. San Diego: Academic Press.
20. Ferro-Novick S, Jahn R (1994): Vesicle fusion from yeast to man. Nature 370: 191-193.
21. Fischer von Mollard G, Südhof TC , Jahn R (1991): A small GTP-binding protein dissociates from synaptic vesicles during exocytosis. Nature. 349: 79-81.
22. Foran P, Lawrence GW, Shone CC et al. (1996): Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release. Biochemistry 35: 2630-6.
23. Frangez R, Dolinsek J, Demsar F et al. (1994): Chronic denervation caused by botulinum neurotoxin as a model of a neuromuscular disease. Annals of the New York Academy of Sciences. 710: 88-93.
24. Gaisano HY, Sheu L, Foskett JK et al. (1994): Tetanus toxin light chain cleaves a vesicle-associated membrane protein (VAMP) isiform 2 in rat pancreatic zymogen granules and inhibits enzyme secretion. J. Biol. Chem. 269: 17062-6.
25. Galli T, Chilcote T, Mundigl O et al. (1994): Tetanus toxin-mediated cleavage of cellubrevin impairs exocytosis of transferrin receptor-containing vesicles in CHO cells. J. Cell Biol. 125: 1015-24.
26. Gansel M, Penner R, Dreyer F (1987): Distinct sites of action of clostridial neurotoxins revealed by double-poisoning of mouse motor nerve terminals. Pflügers Arch. Eur. J. Physiol. 409: 533-9.
27. Gray EG, Whittaker VP (1962): The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogeneization and centrifugation. J. Anat. Lond. 96: 79-88.
28. Habermann E, Dreyer F (1986): Clostridial neurotoxins: handling and action at the cellular and molecular level. Current Topics Microbiol. Immunol. 129: 93-179.
29. Habermann E, Muller H, Hudel M (1988): Tetanus toxin and botulinum A and C neurotoxins inhibit noradrenaline release from cultured mouse brain. J. Neurochem. 51: 522-7.
30. Hayashi T, McMahon H, Yamasaki S et al. (1994): Synaptic vesicle membrane fusion complex: action of clostridial neurotoxins on assembly. EMBO J. 13: 5051-61.
31. Hayashi T, Yamasaki S, Nauenburg S et al. (1995): Disassembly of the reconstituted synaptic vesicle membrane fusion complex in vitro. EMBO J. 14: 2317-25.
32. Hughes AJ (1994): Botulinum toxin in clinical practice. Drugs. 48: 888-93.
33. Hunt JM, Bommert K, Charlton MP et al. (1994): A Post-docking role for synaptobrevin in synaptic vesicle fusion. Neuron. 12: 1269-79.
34. Ikonen E, Tagaya M, Ullrich O et al. (1995): Different requirements for NSF, SNAP, and rab proteins in apical and basolateral transport in MDCK cells. Cell. 81:571-50.
35. Jankovic J (1994): Botulinum toxin in movement disorders. Current Opinion in Neurology. 7: 358-66.
36. Kistner A, Habermann E (1992): Reductive cleavage of tetanus toxin and botulinum neurotoxin A by the thioredoxin system from brain. Evidence for two redox isomers of tetanus toxin. Naunyn. Schmiedebergs Arch. Pharmacol. 345: 227-34
37. Link E, Edelmann L, Chou et al. (1992): Tetanus toxin action: inhibition of neurotransmitter release linked to synaptobrevin proteolysis. Biochem. Biophys. Res. Comm. 189: 1017-23.
38. Link E, McMahon H, Fischer von Mollard G et al. (1993): Cleavage of cellubrevin by tetanus toxin does not affect fusion of early endosomes. J. Bioi. Chem. 268: 18423-6.
39. Link E, Blasi J, Chapman ER et al. (1994): Tetanus and botulinal neurotoxins: tools to understand exocytosis in neurons. Advances in Second Messenger and Phosphoprotein Research 29: 47-58.
40. Llinas R, Sugimori M, Chu D et al. (1994): Transmission at the squid giant synapse was blocked by tetanus toxin by affecting synaptobrevin, a vesicle-bound protein. J. Physiol. (London) 477.1: 129-33.
41. Manning KA, Erichsen JT, Evinger C (1990): Retrograde transneuronal transport properties of fragment C of tetanus toxin. Neuroscience. 34: 251-63
42. Marxen P, Bigalke H (1989): Tetanus toxin: inhibitory action in chromaffin cells is initiated by specified types of gangliosides and promoted in low ionic strength solution. Neurosci. Lett. 107: 261-6.
43. McMahon HT, Rosenthal L, Meldolesi J et al. (1990): α-Latrotoxin releases both vesicular and cytoplasmic glutamate from isolated nerve terminals. J. Neurochem. 55: 2039-47.
44. McMahon HT, Foran P, Dolly JO et al. (1992): Tetanus toxin and botulinum toxins type A and B inhibit gltamate, gamma-aminobutyric acid, aspartate, and metenkephalin release from synaptosomes. Clues to the focus of action. J. Biol. Chem. 267: 21338-43.
45. McMahon HT, Ushkaryov YA, Edelmann L et al. (1993): Cellubrevin is a ibiquitous tetanus-toxin substrate homologous to a putative synaptic vesicle fusion protein. Nature. 364: 346-9.
46. Middlebrook JL. (1989): Cell surface receptors for protein toxins. In Botulinum neurotoxin and tetanus toxin (Simpson LL, ed) San Diego: Academic Press.
47. Mochida S, Poulain B, Weller U et al. (1989): Light chain of tetanus toxin intracellularly inhibits acetylcholine release at neuro-neuronal synapses, and its internalization is mediated by heavy chain. FEBS Lett. 253: 47-51.
48. Mochida S, Poulain B, Eisel U et al. (1990): Exogenous mRNA encoding tetanus or botulinum neurotoxins expressed in Aplysia neurons. Proc. Acad. Sci USA. 87: 7844-8.
49. Mochida S, Saisu H, Kobayashi H et al. (1995): Impairment of synatxin by botulinum neurotoxin C1 or antibodies inhibits acetylcholine release but not Ca2+ channel activity. Neuroscience. 65: 905-15.
50. Molgo J, Lemeignan M, Thesleff S (1987): Aminoglycosides and 3,4-diaminopyridine on neuromuscular block caused by botulinum type A toxin. Muscle Nerve. 10: 464-70.
51. Molgo J, Thesleff S (1984): Studies on the mode of action of botulinum toxin type A at the frog neuromuscular junction. Brain Res. 297: 309-16.
52. Montecucco C (1986): How do tetanus and botulinum toxins bind to neuronal membranes? Trends Biochem Sci. 11: 314-7.
53. Montecucco C, Schiavo G (1993): Tetanus and botulism neurotoxins: a new group of zinc proteases. Trends Biochem. Sci. 18: 324-7.
54. Montecucco C, Schiavo G. (1994): Mechanism of action of tetanus and botulinum neurotoxins. Mol Microbiol. 13: 1-8.
55. Nicholls D.G. (1978): Calcium transport and proton electrochemical potential potential gradient in mitochondria from guinea-pig cerebral cortex and rat heart. Biochem. J. 170: 511-22.
56. Nicholls DG, Sihra TS (1986): Synaptosomes posses and exocytotic pool of glutamate. Nature 321: 772-3.
57. Nicholls DG, Sihra TS, Snachez-Prieto J (1987): Calcium-dependent and -independent release of glutamate from synaptosomes monitored by continuous fluorometry. J. Neurochem. 49: 50-7.
58. Nicholls DG. (1989): Release of glutamate, aspartate, and γ-aminobutyric acid from isolated nerve terminals. J. Neurochem. 52: 331-41.
59. Niemann H (1991):Molecular biology of clostridial neurotoxins. In: Sourcebook of Bacterial Toxins (Alouf JE, Freer JH, ed) pp303-48, New York: Academic Press.
60. Niemann H, Blasi J, Jahn R (1994): Clostridial neurotoxins: new tools for dissecting exocytosis. Trends Cell Biol. 4: 179-85.
61. Nishiki T, Kamata Y, Nemoto Y et al. (1994): Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes. J. Biol. Chem. 269: 10498-503.
62. Otto H, Hanson PI, Chapman ER et al. (1995): Poisoning by botulinum neurotoxin A does not inhibit formation or disassembly of the synaptosomal fusion complex. Biochem. Biophys. Res, Commun. 212: 945-52.
63. Pellegrini LL, O'Connor V, Betz H. (1994): Fusion complex formation protects synaptobrevin against proteolysis by tetanus toxin light chain. FEBS Lett. 353:319-23.
64. Pellegrini LL, Oconnor V, Lottspeich F et al. (1995): Clostridial neurotoxins compromise the stability of a low-energy SNARE complex mediating NSF activation of synaptic vesicle fusion EMBO J. 14: 4705-13.
65. Penner R, Neher E, Dreyer F (1986): Intracellularly injected tetanus toxin inhibits exocytosis in bovine adrenal chromaffin cells. Nature 324: 76-8.
66. Poulain B, Baux G, Tauc L (1986): Presynaptic transmitter content controls the number of quanta released at the neuro-neuronal cholinergic synapse Proc. Natl. Acad. Sci. USA 83: 170-3.
67. Poulain B, Mochida S, Wadsworth JD et al. (1990): Inhibition of neurotransmitter release by botulinum neurotoxins and tetanus toxin at Aplysia synapses: role of the constituent chains. J. Physiol. (Paris) 84: 247-61.
68. Poulain B, Wadsworth JDF, Maisey EA et al. (1989): Inhibition of transmitter release by botulinum neurotoxin A. Eur. J. Biochem. 185: 197-203.
69. Ralston E, Beushausen S, Ploug T. (1994): Expression of the synaptic vesicle proteins VAMPs/synaptobrevins 1 and 2 in non-neural tissues. J. Biol. Chem. 269: 15403-6.
70. Sadoul K, Lang J, Montecucco C et al. (1995): SNAP-25 is expressed in isletd of Langerhans and is involved in insulin release J. Cell Biol. 128: 1019-28.
71. Sanchez-Prieto J, Sihra TS, Nicholls DG. (1987a): Characterization of the exocytotic release of glutamate from guinea pig cerebral cortical synaptosomes. J. Neurochem. 49: 58-64.
72. Sanchez-Prieto J, Sihra TS, Evans D et al. (1987b): Botulinum toxin A blocks glutamate exocytosis from guinea-pig cerebral cortical synaptosomes. Eur. J. Biochem. 165: 675-81.
73. Schiavo G, Benfenati F, Poulain B et al. (1992): Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 359: 832-5.
74. Schiavo G, Rossetto O, Catsicas S et al. (1993a): Identification of the nerve terminal targets of botulinum neurotoxin serotype-A, serotype-D, and serotype-E. J. Biol. Chem. 268: 23784-7.
75. Schiavo G, Santucci A, DasGupta BR et al. (1993b): Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds. FEBS Lett 335: 99-103.
76. Schiavo G, Shone CC, Rossetto O et al. (1993c): Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin. J. Biol. Chem. 268: 11516-9.
77. Schiavo G, Shone CC, Bennett MK et al. (1995): Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of syntaxins. J. Biol. Chem. 270: 10566-70.
78. Simpson LL (ed) (1989): Botulinum neurotoxin and tetanus toxin. San Diego: Academic Press.
79. Simpson LL, Lake P, Kozaki S (1990): Isolation and characterization of a novel human monoclonal antibody that neutralizes tetanus toxin. J. Pharmacol. Exp. Ther. 254: 98-103.
80. Stahl B, Fischer von Mollard G, Walch-Solimena C et al. (1994): GTP-cleavage by the small GTP-binding protein Rab3A is associated with exocytosis of synaptic vesicles induced by a-latrotoxin. J. Biol. Chem. 269: 24770-6.
81. Stahl B, Chou JH, Li C et al. (1996): Rab3 reversibly recruits rabphilin to synaptic vesicles by a mechanism analogous to raf recruitment by ras. EMBO J. 15: 1799-809.
82. Steinhardt RA, Bi G, Alderton JM (1994): Cell membrane resealing by a vesicular mechanism similar to neurotransmitter release. Science 263: 390-3.
83. Sweeney ST, Broadie K, Keane J et al. (1995): Targeted expression of tetanus toxin light chain in Drosophila Specifically eliminates synaptic transmission and causes behavioral defects. Neuron. 14: 341-51.
84. Tauc L, Hoffmann A, Tsujii S et al. (1974): Transmission abolished on a cholinergic synapse after injection of AChE into the presynaptic neuron. Nature. 250: 496-8.
85. Tibbs GR, Barrie AP, Van Mieghem FJE et al. (1989): Repetitive action potentials in isolated nerve terminals in the presence of 4-aminopyridine: effecs on cytosolic free Ca2+ and glutamate release. J. Neurochem. 53: 1693-9.
86. Turner TJ, Dunlap K (1995): Prolonged time course of glutamate release from nerve terminals: relationship between stimulus duration and the secretory event. J. Neurochem. 64: 2022-33
87. Volchuk A, Mitsumoto Y, He L et al. (1994): Expression of veicle-associated membrane protein 2 (VAMP-2)/synaptobrevin II and celubrevin in rat skeletal muscle and in a muscle cell line. Biochem. J. 304: 139-45.
88. Whittaker VP, Michaelson IA, Kirklan RJA (1964): The separation of synaptic vesicles from nerve-endings particles ("synaptosomes"). Biochem J. 90: 293-303.
89. Williamson LC, Halpern JL, Montecucco C et al. (1996): Clostridial neurotoxins and substrate proteolysis in intact neurons. Botulinum neurotoxin C acts on synaptosomal-associated protein of 25 kDa. J. Biol. Chem. 271: 7694-9.
90. Yamasaki S, Baumeister A et al. (1994a): Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin. J. Biol. Chem. 269: 12764 - 72.
91. Yamasaki S, Binz T, Hayashi T et al. (1994b): Botulinum neurotoxin type G proteolyses the Ala81-Ala82 bond of rat synaptobrevin 2. Biochem. Biophys. Res. Comm. 200: 829-5.